FOL-005 Final Trial For Alopecia

On May 6, 2021 the Swedish biotech company Follicum announced results from its pivotal phase 2 trial which represented the first time its candidate peptide FOL-005 was tested topically to treat male pattern baldness. FOL-005 Grew Hair, But Not Quite Enough To keep things succinct, FOL-005 did not reach its goal in the phase 2…